|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011.
|
|
2
|
Siegel RL, Miller KD, Fuchs HE and Jemal
A: Cancer Statistics, 2021. CA Cancer J Clin. 71:7–33. 2021.
|
|
3
|
Estevez-Ordonez D, Montalvan-Sanchez EE,
Wong RE, Montalvan-Sanchez DM, Rodriguez-Murillo AA, Dominguez RL
and Morgan DR: Health barriers and patterns of gastric cancer care
in rural central American resource-limited settings. JAMA Oncol.
4:1131–1133. 2018.
|
|
4
|
Yeoh KG and Tan P: Mapping the genomic
diaspora of gastric cancer. Nat Rev Cancer. 22:71–84. 2022.
|
|
5
|
Walker MM, Teare L and McNulty C: Gastric
cancer and Helicobacter pylori: The bug, the host or the
environment? Postgrad Med J. 84:169–170. 2008.
|
|
6
|
Zeyaullah M, AlShahrani AM and Ahmad I:
Association of helicobacter pylori infection and host cytokine gene
polymorphism with gastric cancer. Can J Gastroenterol Hepatol.
2021:88106202021.
|
|
7
|
Zeng Y and Jin RU: Molecular pathogenesis,
targeted therapies, and future perspectives for gastric cancer.
Semin Cancer Biol. 86:566–582. 2021.
|
|
8
|
Trams EG, Lauter CJ, Salem N and Heine U:
Exfoliation of membrane ecto-enzymes in the form of micro-vesicles.
Biochim Biophys Acta. 645:63–70. 1981.
|
|
9
|
Li Y, Tian L, Zhao T and Zhang J: A
nanotherapeutic system for gastric cancer suppression by
synergistic chemotherapy and immunotherapy based on iPSCs and DCs
exosomes. Cancer Immunol Immunother. 72:1673–1683. 2023.
|
|
10
|
Chen BY, Sung CWH, Chen C, Cheng CM, Lin
DP, Huang CT and Hsu MY: Advances in exosomes technology. Clin Chim
Acta. 493:14–19. 2019.
|
|
11
|
Beit-Yannai E, Tabak S and Stamer WD:
Exosomes. Nat Biotechnol. 38:11502020.
|
|
12
|
Ayyar KK and Moss AC: Exosomes in
intestinal inflammation. Front Pharmacol. 12:6585052021.
|
|
13
|
Beit-Yannai E, Tabak S and Stamer WD:
Physical exosome: Exosome interactions. J Cell Mol Med.
22:2001–2006. 2018.
|
|
14
|
Wang J, Liu Y, Sun W, Zhang Q, Gu T and Li
G: Plasma exosomes as novel biomarker for the early diagnosis of
gastric cancer. Cancer Biomark. 21:805–812. 2018.
|
|
15
|
Xia Y, Hu X, Di K, Liu C, Tan T, Lin Y, Xu
H, Xie H, Wang S, Yang Z, et al: Combined detection of exosome
concentration and tumor markers in gastric cancer. J Biomed
Nanotechnol. 16:252–258. 2020.
|
|
16
|
Exosomes. Nat Biotechnol. 38:11502020.
|
|
17
|
Li J, Zhang Y and Luo B: Effects of
exosomal viral components on the tumor microenvironment. Cancers
(Basel). 14:35522022.
|
|
18
|
Pegtel DM and Gould SJ: Exosomes. Annu Rev
Biochem. 88:487–514. 2019.
|
|
19
|
Wang X, Huang J, Chen W, Li G, Li Z and
Lei J: The updated role of exosomal proteins in the diagnosis,
prognosis, and treatment of cancer. Exp Mol Med. 54:1390–1400.
2022.
|
|
20
|
Wang M, Zhao X, Huang F, Wang L, Huang J,
Gong Z and Yu W: Exosomal proteins: Key players mediating
pre-metastatic niche formation and clinical implications (Review).
Int J Oncol. 58:42021.
|
|
21
|
Huda MN and Nurunnabi M: Potential
application of exosomes in vaccine development and delivery. Pharm
Res. 39:2635–2671. 2022.
|
|
22
|
Wang W, Zhu N, Yan T, Shi YN, Chen J,
Zhang CJ, Xie XJ, Liao DF and Qin L: The crosstalk: Exosomes and
lipid metabolism. Cell Commun Signal. 18:1192020.
|
|
23
|
Puno MR, Weick E-M, Das M and Lima CD:
SnapShot: The RNA exosome. Cell. 179:282–282.e1. 2019.
|
|
24
|
Kilchert C, Wittmann S and Vasiljeva L:
The regulation and functions of the nuclear RNA exosome complex.
Nat Rev Mol Cell Biol. 17:227–239. 2016.
|
|
25
|
Bach DH, Hong JY, Park HJ and Lee SK: The
role of exosomes and miRNAs in drug-resistance of cancer cells. Int
J Cancer. 141:220–230. 2017.
|
|
26
|
Wu Z, Fang ZX, Hou YY, Wu BX, Deng Y, Wu
HT and Liu J: Exosomes in metastasis of colorectal cancers: Friends
or foes? World J Gastrointest Oncol. 15:731–756. 2023.
|
|
27
|
Patil AA and Rhee WJ: Exosomes:
Biogenesis, composition, functions, and their role in
pre-metastatic niche formation. Biotechnol Bioprocess Engineering.
24:689–701. 2019.
|
|
28
|
Kanemoto S, Nitani R, Murakami T, Kaneko
M, Asada R, Matsuhisa K, Saito A and Imaizumi K: Multivesicular
body formation enhancement and exosome release during endoplasmic
reticulum stress. Biochem Biophys Res Commun. 480:166–172.
2016.
|
|
29
|
Xia Z, Qing B, Wang W, Gu L, Chen H and
Yuan Y: Formation, contents, functions of exosomes and their
potential in lung cancer diagnostics and therapeutics. Thorac
Cancer. 12:3088–3100. 2021.
|
|
30
|
Wang Z, Zhao Z, Gao B and Zhang L: Exosome
mediated biological functions within skeletal microenvironment.
Front Bioeng Biotechnol. 10:9539162022.
|
|
31
|
Zhang Y, Liu Y, Liu H and Tang WH:
Exosomes: Biogenesis, biologic function and clinical potential.
Cell Biosci. 9:192019.
|
|
32
|
Kuang G, Wang Z, Luo C, Luo J and Wang J:
Mechanism of exosomes in the tumor microenvironment in the abscopal
effect (Review). Int J Oncol. 62:22023.
|
|
33
|
Han L, Lam EWF and Sun Y: Extracellular
vesicles in the tumor microenvironment: Old stories, but new tales.
Mol Cancer. 18:592019.
|
|
34
|
Anderson NM and Simon MC: The tumor
microenvironment. Curr Biol. 30:R921–R925. 2020.
|
|
35
|
Guerra E, Di Pietro R, Basile M, Trerotola
M and Alberti S: Cancer-Homing CAR-T cells and endogenous immune
population dynamics. Int J Mol Sci. 23:4052021.
|
|
36
|
Kong H and Kim SB: Exosomal communication
between the tumor microenvironment and innate immunity and its
therapeutic application. Immune Netw. 22:e382022.
|
|
37
|
Wang Z, Chen JQ, Liu JL and Tian L:
Exosomes in tumor microenvironment: Novel transporters and
biomarkers. J Transl Med. 14:2972016.
|
|
38
|
Louise F, Ken YL, Richard BSR, Chien-Fu H
and Wu TC: Cervical cancer immunotherapy: Facts and hopes. Clin
Cancer Res. 27:4953–4973. 2021.
|
|
39
|
Li I and Nabet BY: Exosomes in the tumor
microenvironment as mediators of cancer therapy resistance. Mol
Cancer. 18:322019.
|
|
40
|
Hu X, Qiu Y, Zeng X and Wang H: Exosomes
reveal the dual nature of radiotherapy in tumor immunology. Cancer
Sci. 113:1105–1112. 2022.
|
|
41
|
Baig MS, Roy A, Rajpoot S, Liu D, Savai R,
Banerjee S, Kawada M, Faisal SM, Saluja R, Saqib U, et al:
Tumor-derived exosomes in the regulation of macrophage
polarization. Inflamm Res. 69:435–451. 2020.
|
|
42
|
Yunna C, Mengru H, Lei W and Weidong C:
Macrophage M1/M2 polarization. Eur J Pharmacol. 877:1730902020.
|
|
43
|
Xia Y, Rao L, Yao H, Wang Z, Ning P and
Chen X: Engineering macrophages for cancer immunotherapy and drug
delivery. Adv Mater. 32:e20020542020.
|
|
44
|
Pritchard A, Tousif S, Wang Y, Hough K,
Khan S, Strenkowski J, Chacko BK, Darley-Usmar VM and Deshane JS:
Lung tumor Cell-Derived exosomes promote M2 macrophage
polarization. Cells. 9:13032020.
|
|
45
|
Khan FH, Reza MJ, Shao YF, Perwez A, Zahra
H, Dowlati A and Abbas A: Role of exosomes in lung cancer: A
comprehensive insight from immunomodulation to theragnostic
applications. Biochim Biophys Acta Rev Cancer. 1877:1887762022.
|
|
46
|
Guo W, Li Y, Pang W and Shen H: Exosomes:
A potential therapeutic tool targeting communications between tumor
cells and macrophages. Mol Ther. 28:1953–1964. 2020.
|
|
47
|
Bożyk A, Wojas-Krawczyk K, Krawczyk P and
Milanowski J: Tumor Microenvironment-A short review of cellular and
interaction diversity. Biology (Basel). 11:9292022.
|
|
48
|
Burassakarn A, Srisathaporn S, Pientong C,
Wongjampa W, Vatanasapt P, Patarapadungkit N and Ekalaksananan T:
Exosomes-carrying Epstein-Barr virus-encoded small RNA-1 induces
indoleamine 2, 3-dioxygenase expression in tumor-infiltrating
macrophages of oral squamous-cell carcinomas and suppresses T-cell
activity by activating RIG-I/IL-6/TNF-α pathway. Oral Oncol.
117:1052792021.
|
|
49
|
Shen Y, Guo D, Weng L, Wang S, Ma Z, Yang
Y, Wang P, Wang J and Cai Z: Tumor-derived exosomes educate
dendritic cells to promote tumor metastasis via
HSP72/HSP105-TLR2/TLR4 pathway. Oncoimmunology. 6:e13625272017.
|
|
50
|
Li X, Liu Y, Zheng S, Zhang T, Wu J, Sun
Y, Zhang J and Liu G: Role of exosomes in the immune
microenvironment of ovarian cancer. Oncol Lett. 21:3772021.
|
|
51
|
Rubenich DS, Omizzollo N, Szczepański MJ,
Reichert TE, Whiteside TL, Ludwig N and Braganhol E: Small
extracellular vesicle-mediated bidirectional crosstalk between
neutrophils and tumor cells. Cytokine Growth Factor Rev. 61:16–26.
2021.
|
|
52
|
Zhang X, Shi H, Yuan X, Jiang P, Qian H
and Xu W: Tumor-derived exosomes induce N2 polarization of
neutrophils to promote gastric cancer cell migration. Mol Cancer.
17:1462018.
|
|
53
|
Shao Q, Deng L, Liu H, Liu Z, Chen J,
Jiang F, Yan S and Fu R: Involvement of MM cell-derived exosomes in
T lymphocytes immune responses. Oncol Lett. 20:312020.
|
|
54
|
Ferguson Bennit HR, Gonda A, Kabagwira J,
Oppegard L, Chi D, Licero Campbell J, De Leon M and Wall NR:
Natural killer cell phenotype and functionality affected by
exposure to extracellular survivin and Lymphoma-Derived exosomes.
Int J Mol Sci. 22:12552021.
|
|
55
|
Papademetrio DL, Garcia MN, Grasso D and
Alvarez É: Autophagy-Mediated exosomes as immunomodulators of
natural killer cells in pancreatic cancer microenvironment. Front
Oncol. 10:6229562021.
|
|
56
|
Luo H, Zhou Y, Zhang J, Zhang Y, Long S,
Lin X, Yang A, Duan J, Yang N, Yang Z, et al: NK cell-derived
exosomes enhance the anti-tumor effects against ovarian cancer by
delivering cisplatin and reactivating NK cell functions. Front
Immunol. 13:10876892023.
|
|
57
|
Tumino N, Besi F, Martini S, Di Pace AL,
Munari E, Quatrini L, Pelosi A, Fiore PF, Fiscon G, Paci P, et al:
Polymorphonuclear Myeloid-Derived suppressor cells are abundant in
peripheral blood of cancer patients and suppress natural killer
cell Anti-tumor activity. Front Immunol. 12:8030142022.
|
|
58
|
Yan Y, Wang R, Guan W, Qiao M and Wang L:
Roles of microRNAs in cancer associated fibroblasts of gastric
cancer. Pathol Res Pract. 213:730–736. 2017.
|
|
59
|
Ding X, Xi W, Ji J, Cai Q, Jiang J, Shi M,
Yu Y, Zhu Z and Zhang J: HGF derived from cancer-associated
fibroblasts promotes vascularization in gastric cancer via PI3K/AKT
and ERK1/2 signaling. Oncol Rep. 40:1185–1195. 2018.
|
|
60
|
Ma J, Song X, Xu X and Mou Y:
Cancer-Associated-Fibroblasts promote the chemo-resistance in
gastric cancer through secreting IL-11 targeting JAK/STAT3/Bcl2
pathway. Cancer Res Treat. 51:194–210. 2019.
|
|
61
|
Wei R, Song J and Liu X, Huo S, Liu C and
Liu X: Immunosuppressive MFAP2+ cancer associated fibroblasts
conferred unfavorable prognosis and therapeutic resistance in
gastric cancer. Cell Oncol (Dordr). Aug 4–2023. View Article : Google Scholar : Epub ahead of
print.
|
|
62
|
Lu G, Du R, Dong J, Sun Y, Zhou F, Feng F,
Feng B, Han Y and Shang Y: Cancer associated fibroblast derived
SLIT2 drives gastric cancer cell metastasis by activating NEK9.
Cell Death Dis. 14:4212023.
|
|
63
|
Iha K, Sato A, Tsai HY, Sonoda H, Watabe
S, Yoshimura T, Lin MW and Ito E: Gastric cancer cell-derived
exosomal GRP78 enhances angiogenesis upon stimulation of vascular
endothelial cells. Curr Issues Mol Biol. 44:6145–6157. 2022.
|
|
64
|
Xue X, Huang J, Yu K, Chen X, He Y, Qi D
and Wu Y: YB-1 transferred by gastric cancer exosomes promotes
angiogenesis via enhancing the expression of angiogenic factors in
vascular endothelial cells. BMC Cancer. 20:9962020.
|
|
65
|
Zhou Z, Zhang H, Deng T, Ning T, Liu R,
Liu D, Bai M, Ying G and Ba Y: Exosomes Carrying MicroRNA-155
target forkhead Box O3 of endothelial cells and promote
angiogenesis in gastric cancer. Mol Ther Oncolytics.
25:2622022.
|
|
66
|
Oya Y, Hayakawa Y and Koike K: Tumor
microenvironment in gastric cancers. Cancer Sci. 111:2696–2707.
2020.
|
|
67
|
Hao Y, Zheng C, Wang L, Hu Y, Guo H, Song
Q, Zhang H, Zhang Z and Zhang Y: Covalent self-assembled
nanoparticles with pH-dependent enhanced tumor retention and drug
release for improving tumor therapeutic efficiency. J Mater Chem B.
5:2133–2144. 2017.
|
|
68
|
Zhu KG, Yang J, Zhu Y, Zhu Q, Pan W, Deng
S, He Y, Zuo D, Wang P, Han Y and Zhang HY: The microprotein
encoded by exosomal lncAKR1C2 promotes gastric cancer lymph node
metastasis by regulating fatty acid metabolism. Cell Death Dis.
14:7082023.
|
|
69
|
Wang R, Liang L, Matsumoto M, Iwata K,
Umemura A and He F: Reactive Oxygen species and NRF2 signaling,
friends or foes in cancer? Biomolecules. 13:3532023.
|
|
70
|
Chen H, Sun Q, Zhang C, She J, Cao S, Cao
M, Zhang N, Adiila AV, Zhong J, Yao C, et al: Identification and
Validation of CYBB, CD86, and C3AR1 as the key genes related to
macrophage infiltration of gastric cancer. Front Mol Biosci.
8:7560852021.
|
|
71
|
Zhao LX, Zhang K, Shen BB and Li JN:
Mesenchymal stem cell-derived exosomes for gastrointestinal cancer.
World J Gastrointest Oncol. 13:1981–1996. 2021.
|
|
72
|
Tian X, Shen H, Li Z, Wang T and Wang S:
Tumor-derived exosomes, myeloid-derived suppressor cells, and tumor
microenvironment. J Hematol Oncol. 12:842019.
|
|
73
|
Liu K, Gao X, Kang B, Liu Y, Wang D and
Wang Y: The role of tumor stem cell exosomes in cancer invasion and
metastasis. Front Oncol. 12:8365482022.
|
|
74
|
da Costa VR, Araldi RP, Vigerelli H,
D'Ámelio F, Mendes TB, Gonzaga V, Policíquio B, Colozza-Gama GA,
Valverde CW and Kerkis I: Exosomes in the tumor microenvironment:
From biology to clinical applications. Cells. 10:26172021.
|
|
75
|
Wang T, Nasser MI, Shen J, Qu S, He Q and
Zhao M: Functions of exosomes in the triangular relationship
between the tumor, inflammation, and immunity in the tumor
microenvironment. J Immunol Res. 2019:41978292019.
|
|
76
|
Lopez K, Lai SWT, Lopez Gonzalez EDJ,
Dávila RG and Shuck SC: Extracellular vesicles: A dive into their
role in the tumor microenvironment and cancer progression. Front
Cell Dev Biol. 11:11545762023.
|
|
77
|
Thakur A, Johnson A, Jacobs E, Zhang K,
Chen J, Wei Z, Lian Q and Chen HJ: Energy sources for exosome
communication in a cancer microenvironment. Cancers (Basel).
14:16982022.
|
|
78
|
Yan Y, Fu G, Ye Y and Ming L: Exosomes
participate in the carcinogenesis and the malignant behavior of
gastric cancer. Scand J Gastroenterol. 52:499–504. 2017.
|
|
79
|
Yoon JH, Choi BJ, Nam SW and Park WS:
Gastric cancer exosomes contribute to the field cancerization of
gastric epithelial cells surrounding gastric cancer. Gastric
Cancer. 25:490–502. 2022.
|
|
80
|
Liang ZF, Zhang Y, Guo W, Chen B, Fang S
and Qian H: Gastric cancer stem cell-derived exosomes promoted
tobacco smoke-triggered development of gastric cancer by inducing
the expression of circ670. Med Oncol. 40:242022.
|
|
81
|
Chang L, Gao H, Wang L, Wang N, Zhang S,
Zhou X and Yang H: Exosomes derived from miR-1228 overexpressing
bone marrow-mesenchymal stem cells promote growth of gastric cancer
cells. Aging (Albany NY). 13:11808–11821. 2021.
|
|
82
|
Lin S, Que Y, Que C, Li F, Deng M and Xu
D: Exosome miR-3184-5p inhibits gastric cancer growth by targeting
XBP1 to regulate the AKT, STAT3, and IRE1 signalling pathways. Asia
Pac J Clin Oncol. 19:e27–e38. 2023.
|
|
83
|
Piao HY, Guo S, Wang Y and Zhang J:
Exosome-transmitted lncRNA PCGEM1 promotes invasive and metastasis
in gastric cancer by maintaining the stability of SNAI1. Clin
Transl Oncol. 23:246–256. 2021.
|
|
84
|
Yang H, Zhang H, Ge S, Ning T, Bai M, Li
J, Li S, Sun W, Deng T, Zhang L, et al: Exosome-Derived miR-130a
activates angiogenesis in gastric cancer by targeting C-MYB in
vascular endothelial cells. Mol Ther. 26:2466–2475. 2018.
|
|
85
|
Gu H, Ji R, Zhang X, Wang M, Zhu W, Qian
H, Chen Y, Jiang P and Xu W: Exosomes derived from human
mesenchymal stem cells promote gastric cancer cell growth and
migration via the activation of the Akt pathway. Mol Med Rep.
14:3452–3458. 2016.
|
|
86
|
Gao Q, Cui L, Huang C, Zhou C, Chen B,
Wang Q, Wang M, Shene B, Xu W and Zhu W: Gastric cancer-derived
exosomes induce PD-L1 expression on human bone marrow mesenchymal
stem cells through the AKT-c-Myc signal axis. Front Life Sci.
442–451. 2022.
|
|
87
|
Fu H, Yang H, Zhang X, Wang B, Mao J, Li
X, Wang M, Zhang B, Sun Z, Qian H and Xu W: Exosomal TRIM3 is a
novel marker and therapy target for gastric cancer. J Exp Clin
Cancer Res. 37:1622018.
|
|
88
|
Sun Y, Jin J, Jing H, Lu Y, Zhu Q, Shu C,
Zhang Q and Jing D: ITIH4 is a novel serum biomarker for early
gastric cancer diagnosis. Clin Chim Acta. 523:365–373. 2021.
|
|
89
|
Wang S, He Y, Lu J, Wang Y, Wu X, Yan G,
Fang X and Liu B: All-in-One strategy for downstream molecular
profiling of tumor-derived exosomes. ACS Appl Mater Interfaces.
14:36341–36352. 2022.
|
|
90
|
Dong Z, Sun X, Xu J, Han X, Xing Z, Wang
D, Ge J, Meng L and Xu X: Serum Membrane Type 1-Matrix
Metalloproteinase (MT1-MMP) mRNA Protected by exosomes as a
potential biomarker for gastric cancer. Med Sci Monit.
25:7770–7783. 2019.
|
|
91
|
Cai C, Zhang H, Zhu Y, Zheng P, Xu Y, Sun
J, Zhang M, Lan T, Gu B, Li S and Ma P: Serum exosomal long
noncoding RNA pcsk2-2:1 as a potential novel diagnostic biomarker
for gastric cancer. OncoTargets Ther. 12:10035–10041. 2019.
|
|
92
|
Joo HS, Jeon HY, Hong EB, Kim HY and Lee
JM: Exosomes for the diagnosis and treatment of dementia. Curr Opin
Psychiatry. 36:119–125. 2023.
|
|
93
|
Aheget H, Mazini L, Martin F, Belqat B,
Marchal JA and Benabdellah K: Exosomes: Their role in pathogenesis,
diagnosis and treatment of diseases. Cancers (Basel).
13:842020.
|
|
94
|
Wang J, Sun X, Zhao J, Yang Y, Cai X, Xu J
and Cao P: Exosomes: A novel strategy for treatment and prevention
of diseases. Front Pharmacol. 8:3002017.
|
|
95
|
Jiang L, Chen W, Ye J and Wang Y:
Potential role of exosomes in ischemic stroke treatment.
Biomolecules. 115:122022.
|
|
96
|
You D, Kundu S, Schmaier AH, Khorana AA
and McCrae KR: Exosome polyphosphate mediates the activation of
FXII by cancer cell-derived exosomes. Blood. 132:38002018.
|
|
97
|
Zhang H, Wang Y, Bai M, Wang J, Zhu K, Liu
R, Ge S, Li J, Ning T, Deng T, et al: Exosomes serve as
nanoparticles to suppress tumor growth and angiogenesis in gastric
cancer by delivering hepatocyte growth factor siRNA. Cancer Sci.
109:629–641. 2018.
|
|
98
|
Wang X, Zhang H, Bai M, Ning T, Ge S, Deng
T, Liu R, Zhang L, Ying G and Ba Y: Exosomes serve as nanoparticles
to deliver Anti-miR-214 to reverse chemoresistance to cisplatin in
gastric cancer. Mol Ther. 26:774–783. 2018.
|
